참고문헌
- Ospina M, Harstall C. Prevalence of chronic pain: an overview. Edmonton, Alberta Heritage Foundation for Medical Research. 2002.
- Elzahaf RA, Tashani OA, Unsworth BA, Johnson MI. The prevalence of chronic pain with an analysis of countries with a Human Development Index less than 0.9: a systematic review without meta-analysis. Curr Med Res Opin 2012; 28: 1221-9. https://doi.org/10.1185/03007995.2012.703132
- Venekamp RP, Rovers MM, Hoes AW, Knol MJ. Subgroup analysis in randomized controlled trials appeared to be dependent on whether relative or absolute effect measures were used. J Clin Epidemiol 2014; 67: 410-5. https://doi.org/10.1016/j.jclinepi.2013.11.003
- Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012; 344: e1553. https://doi.org/10.1136/bmj.e1553
- Varadhan R, Wang SJ. Standardization for subgroup analysis in randomized controlled trials. J Biopharm Stat 2014; 24: 154-67. https://doi.org/10.1080/10543406.2013.856023
- Byth K, Gebski V. Factorial designs: a graphical aid for choosing study designs accounting for interaction. Clin Trials 2004; 1: 315-25. https://doi.org/10.1191/1740774504cn026oa
- McCormack R, Lamontagne M, Vannabouathong C, Deakon RT, Belzile EL. Comparison of the 3 different injection techniques used in a randomized controlled study evaluating a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (Cingal) for osteoarthritis of the knee: a subgroup analysis. Clin Med Insights Arthritis Musculoskelet Disord 2017; 10: 1179544117725026.
- Saragiotto BT, Maher CG, Moseley AM, Yamato TP, Koes BW, Sun X, et al. A systematic review reveals that the credibility of subgroup claims in low back pain trials was low. J Clin Epidemiol 2016; 79: 3-9. https://doi.org/10.1016/j.jclinepi.2016.06.003
- Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med 1992; 116: 78-84. https://doi.org/10.7326/0003-4819-116-1-78
- Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010; 340: c117. https://doi.org/10.1136/bmj.c117
- Oxman A, Guyatt G, Cook D, Montori V. Summarizing the evidence. In: Users' guides to the medical literature: a manual for evidence-based clinical practice. Edited by Guyatt G, Rennie D. Chicago, AMA Press. 2002, pp 155-173.
- Akl EA, Sun X, Busse JW, Johnston BC, Briel M, Mulla S, et al. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol 2012; 65: 262-7. https://doi.org/10.1016/j.jclinepi.2011.04.015
- Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat Theory Methods 1980; 9: 1043-69. https://doi.org/10.1080/03610928008827941
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74. https://doi.org/10.2307/2529310
- Harris RJ, Quade D. The minimally important difference significant criterion for sample size. J Educ Stat 1992; 17: 27-49. https://doi.org/10.3102/10769986017001027
- Lachenbruch PA. A note on sample size computation for testing interactions. Stat Med 1988; 7: 467-9. https://doi.org/10.1002/sim.4780070403
- Mistry D, Patel S, Hee SW, Stallard N, Underwood M. Evaluating the quality of subgroup analyses in randomized controlled trials of therapist-delivered interventions for nonspecific low back pain: a systematic review. Spine (Phila Pa 1976) 2014; 39: 618-29. https://doi.org/10.1097/BRS.0000000000000231
- Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005; 365: 176-86. https://doi.org/10.1016/S0140-6736(05)17709-5
- Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review. BMJ 2011; 342: d1569. https://doi.org/10.1136/bmj.d1569
- Barton S, Peckitt C, Sclafani F, Cunningham D, Chau I. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology. Eur J Cancer 2015; 51: 2732-9. https://doi.org/10.1016/j.ejca.2015.08.030